| fgf24 | Stage | Hours | ZFIN expression range | margin | anterior axial hypoblast | otic placode | polster | pectoral fin field | olfactory placode | gut | pharyngeal arch | intermediate cell mass of mesoderm | lens | blood | pectoral fin bud | retina | intestinal bulb | pectoral fin | apical ectodermal ridge pectoral fin | unspecified |
| Zygote | 1-cell | 0 | ||||||||||||||||||
| Cleavage | 2-cell | 0.75 | ||||||||||||||||||
| 4-cell | 1.0 | |||||||||||||||||||
| 8-cell | 1.25 | |||||||||||||||||||
| 16-cell | 1.5 | |||||||||||||||||||
| 32-cell | 1.75 | |||||||||||||||||||
| 64-cell | 2.0 | |||||||||||||||||||
| Blastula | 124-cell | 2.25 | ||||||||||||||||||
| 256-cell | 2.5 | |||||||||||||||||||
| 512-cell | 2.75 | |||||||||||||||||||
| 1k-cell | 3.0 | |||||||||||||||||||
| High | 3.33 | |||||||||||||||||||
| Oblong | 3.66 | |||||||||||||||||||
| Sphere | 4.0 | |||||||||||||||||||
| Dome | 4.33 | |||||||||||||||||||
| 30% epiboly | 4.66 | |||||||||||||||||||
| Gastrula | 50%-epiboly | 5.25 | ! | I | ||||||||||||||||
| Germ-ring | 5.66 | ! | I | |||||||||||||||||
| Shield | 6.0 | ! | I | |||||||||||||||||
| 75% epiboly stage | 8.0 | I | ||||||||||||||||||
| 90% epiboly | 9.0 | I | ||||||||||||||||||
| bud stage | 10.0 | I | ||||||||||||||||||
| Segmentation | 1-4 somites | 10.33 | I | |||||||||||||||||
| 5-9 somites | 11.66 | I | ||||||||||||||||||
| 10-13 somites | 14.0 | I | ||||||||||||||||||
| 14-19 somites | 16.0 | |||||||||||||||||||
| 20-25 somites | 19.0 | ! | I | |||||||||||||||||
| 26+ somites | 22.0 | I | ! | I | ||||||||||||||||
| Pharyngula | Prim-5 | 24.0 | ||||||||||||||||||
| Prim-15 | 30.0 | |||||||||||||||||||
| Prim-25 | 36.0 | I | ||||||||||||||||||
| High-pec | 42.0 | |||||||||||||||||||
| Hatching | Long-pec | 48.0 | ||||||||||||||||||
| Pec-fin | 60.0 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp7 expression at blastula stage. |
| Target Gene | bmp7 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp7 expression at blastula stage. |
| Target Gene | bmp7 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp7 expression at blastula stage. |
| Target Gene | bmp7 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp7 expression at blastula stage. |
| Target Gene | bmp7 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp4 expression at blastula stage. |
| Target Gene | bmp4 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp2b, bmp4 and bmp7 expression at blastula stage. |
| Target Gene | bmp4 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | margin |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp7 expression at blastula stage. |
| Target Gene | bmp7 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | YSL |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp2b expression at blastula stage. |
| Target Gene | bmp2b |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | YSL |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | Microinjection of fgf24 leads to inhibition of bmp2b, bmp4 and bmp7 expression at blastula stage. |
| Target Gene | bmp4 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 4.66 |
| Location of Interaction in evidence | YSL |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Bernard Thisse |
| Journal | Development |
| Year | 2004 |
| Vol | 131 |
| Start Page | 2853 |
| Evidence for Interaction | activation of the FGF/ERK pathway disrupts endoderm formation in the embryo and antagonizes the ability of an activated form of Tar/Acvr1b to induce endoderm at the animal pole. |
| Target Gene | acvr1b |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | overexpression |
| Time of Interaction in evidence | 5.25 |
| Location of Interaction in evidence | mesendoderm |
| Evidence for Direct | 2 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Thierry Lepage |
| Journal | Development |
| Year | 2006 |
| Vol | 133 |
| Start Page | 2189 |
| Evidence for Interaction | triple knockdown of fgf8, Fgf17b and fgf24 resulted in a large increase in the number of endodermal precursors that formed. |
| Target Gene | sox17 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | MASO |
| Time of Interaction in evidence | 10 |
| Location of Interaction in evidence | endoderm |
| Evidence for Direct | 3 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Thierry Lepage |
| Journal | Development |
| Year | 2006 |
| Vol | 133 |
| Start Page | 2189 |
| Evidence for Interaction | triple knockdown of fgf8, Fgf17b and fgf24 resulted in a large increase in the number of endodermal precursors that formed. |
| Target Gene | sox17 |
| Upstream Gene | fgf24 |
| Interaction Type | repress |
| Altered model | MASO |
| Time of Interaction in evidence | 10 |
| Location of Interaction in evidence | endoderm |
| Evidence for Direct | 3 |
| Binding Site Sequence | |
| Location of Site | |
| Last Author | Thierry Lepage |
| Journal | Development |
| Year | 2006 |
| Vol | 133 |
| Start Page | 2189 |